Efficacy, safety and tolerability of neratinib-based therapy in patients from Asia with metastatic HER2+breast cancer and other solid tumors: A pooled analysis of 6 clinical trials | |
Xu, Binghe; Kim, Sung-Bae; Inoue, Kenichi; Shen, Zhen-Zhou; Lee, Ju RueyJiuan; Zhang, Bo; Chow, Louis | |
2018 | |
会议名称 | CANCER RESEARCH |
会议日期 | 2018-02-01 |
收录类别 | CPCI-S |
URL标识 | 查看原文 |
内容类型 | 会议论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6360435 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Xu, Binghe,Kim, Sung-Bae,Inoue, Kenichi,et al. Efficacy, safety and tolerability of neratinib-based therapy in patients from Asia with metastatic HER2+breast cancer and other solid tumors: A pooled analysis of 6 clinical trials[C]. 见:CANCER RESEARCH. 2018-02-01. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论